These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10199348)
1. Are clinical trials of therapeutic agents for MS long enough? Rudge P Lancet; 1999 Mar; 353(9158):1033-4. PubMed ID: 10199348 [No Abstract] [Full Text] [Related]
2. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. McDonald WI; Miller DH; Thompson AJ Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255 [No Abstract] [Full Text] [Related]
3. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis. Paty DW Neurology; 1999 Jul; 53(2):437. PubMed ID: 10430451 [No Abstract] [Full Text] [Related]
4. Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images. Barkhof F; van Waesberghe JH; Uitdehaag BM; Polman CH Ann Neurol; 1997 Dec; 42(6):982. PubMed ID: 9403493 [No Abstract] [Full Text] [Related]
6. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis. Goodkin DE West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569 [TBL] [Abstract][Full Text] [Related]
7. Interferon beta in multiple sclerosis: how much BENEFIT? Pittock SJ Lancet; 2007 Aug; 370(9585):363-4. PubMed ID: 17678997 [No Abstract] [Full Text] [Related]
12. [A short history of beta-interferon therapy of multiple sclerosis]. Stock G; Horowski R Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113 [TBL] [Abstract][Full Text] [Related]
14. Interferon beta-1a and beta-1b for treatment of multiple sclerosis. Kappos L Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424020 [No Abstract] [Full Text] [Related]
15. Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis. Goodin DS Neuroepidemiology; 1999; 18(2):53-63. PubMed ID: 10023128 [TBL] [Abstract][Full Text] [Related]
16. [Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis]. Losy J Neurol Neurochir Pol; 2000; 34(3 Suppl):63-9. PubMed ID: 10983302 [TBL] [Abstract][Full Text] [Related]
17. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?]. MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501 [No Abstract] [Full Text] [Related]